Hospital
Quitman Community Hospital
Quitman Community Hospital was paid $1.06M by Medicaid between Nov 2021 and Nov 2024, across 42 billing codes. Its largest line is 99284, emergency room visit (serious) — 32% of everything it billed.
33Billing provider infoQUITMAN COMMUNITY HOSPITAL
MARKS, MS 38646
MARKS, MS 38646
33aNPI1063177228assigned 11/03/2021
33bProvider typeCritical Access Hospital
28Total paid$1.06M
24GClaims24,287
24DCodes billed42
24AFirst – last monthNov 2021 – Nov 2024
Compared with peers
Next to other Critical Access Hospital providers in Mississippi
Rank by total paid#28 of 32
Median peer was paid$3.94M
This provider vs. median0.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 570 | $7K | |
| 2022 | 8,016 | $330K | |
| 2023 | 10,366 | $421K | |
| 2024incomplete | 5,335 | $298K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 32% | 1,893 | 1,397 | $334K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 19% | 1,642 | 1,278 | $201K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 18% | 1,061 | 722 | $192K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 4.8% | 1,316 | 969 | $50K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 3.8% | 772 | 237 | $40K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3.4% | 592 | 404 | $36K |
| 96521 | 2.1% | 442 | 105 | $22K | |
| 71045 | Radiologic examination, chest; single view | 1.8% | 679 | 464 | $19K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.5% | 981 | 722 | $16K |
| 80053 | Comprehensive metabolic panel | 1.5% | 1,879 | 1,186 | $15K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.3% | 748 | 506 | $14K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.2% | 768 | 558 | $12K |
30 more codes
| 96375 | Therapeutic injection; each additional sequential IV push | 1.0% | 372 | $11K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.0% | 136 | $11K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 977 | $10K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 86 | $8K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 134 | $7K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 735 | $6K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 515 | $6K |
| 36000 | <1% | 1,076 | $6K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 626 | $6K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 152 | $5K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,939 | $5K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 123 | $3K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 122 | $3K |
| 84484 | <1% | 680 | $2K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 448 | $2K |
| 83880 | <1% | 145 | $2K | |
| 93041 | <1% | 141 | $2K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 100 | $2K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 35 | $2K |
| 82962 | <1% | 654 | $2K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 21 | $1K |
| 81003 | <1% | 1,256 | $1K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 131 | $735.24 |
| 83735 | <1% | 145 | $474.44 | |
| 94761 | <1% | 184 | $394.72 | |
| 87807 | <1% | 38 | $356.64 | |
| J3490 | Unclassified drugs | <1% | 115 | $91.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 109 | $51.21 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 103 | $36.00 |
| J1815 | Injection, insulin, per 5 units | 0% | 216 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWILKINSON, LESTER (CHIEF FINANCIAL OFFICER)